Cargando…
Strategies to Optimize Treatment for Locally Advanced Rectal Cancer
SIMPLE SUMMARY: Locally advanced rectal cancer (LARC) is a group of highly heterogeneous tumors. According to the European Society for Medical Oncology (ESMO) guidelines, the risk of recurrence can be classified by magnetic resonance imaging (MRI) as low to very high. In the era of precision medicin...
Autores principales: | Hu, Xiaoyu, Xue, Zhuang, He, Kewen, Tian, Yaru, Chen, Yu, Zhao, Mengyu, Yu, Jinming, Yue, Jinbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818694/ https://www.ncbi.nlm.nih.gov/pubmed/36612213 http://dx.doi.org/10.3390/cancers15010219 |
Ejemplares similares
-
Neoadjuvant Chemoradiotherapy Changes the Landscape of Soluble Immune Checkpoint Molecules in Patients With Locally Advanced Rectal Cancer
por: Liu, Chao, et al.
Publicado: (2022) -
Concurrent Chemoradiotherapy Increases the Levels of Soluble Immune Checkpoint Proteins in Patients with Locally Advanced Cervical Cancer
por: Liu, Chao, et al.
Publicado: (2022) -
Genomic features, evolutionary patterns and minimal residual disease at surgical margins as novel prognostic/predictive biomarkers in locally advanced rectal cancer
por: He, Kewen, et al.
Publicado: (2023) -
Consolidation chemotherapy may improve pathological complete response for locally advanced rectal cancer after neoadjuvant chemoradiotherapy: a retrospective study
por: Cui, Jin, et al.
Publicado: (2020) -
GOLPH3 overexpression correlates with poor response to neoadjuvant therapy and prognosis in locally advanced rectal cancer
por: Zhu, Kunli, et al.
Publicado: (2016)